News/Blogs GLP-1s Increasing Plan Drug Spend Whats Next
GLP-1s and Addiction The authors of GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer , appearing in October 2025 in JES, point out that the World Health Organization reported 890 million adults and 60 million children and adolescents had obesity in 2022 globally
When considering GLP-1 medications, patients should always work with their doctor and use licensed pharmacies
As we know, there are more than 230 conditions associated with obesity
How to Activate GLP-1 Naturally
But these are anecdotal observations, not clinical evidence, and they shouldnt be taken as a basis for changing treatment without medical guidance. Alcohol and other substance use disorders are common, but they remain substantially underdiagnosed and undertreated